Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,832 | 84,265 | 111,350 | 112,787 | 126,039 |
| Marketable Securities | 164,637 | 231,233 | 244,509 | 265,971 | 234,981 |
| Other current assets | 0 | 220 | 346 | 471 | 502 |
| TOTAL | $255,934 | $319,721 | $361,641 | $383,793 | $365,262 |
| Non-Current Assets | |||||
| PPE Net | 85,842 | 82,785 | 77,938 | 69,971 | 64,681 |
| Investments And Advances | 84,266 | 53,114 | 40,705 | 52,113 | 106,883 |
| Other Non-Current Assets | 30,186 | 30,924 | 31,467 | 26,707 | 13,482 |
| TOTAL | $200,294 | $166,823 | $150,110 | $148,791 | $185,046 |
| Total Assets | $456,228 | $486,544 | $511,751 | $532,584 | $550,308 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,178 | 7,368 | 4,896 | 2,451 | 857 |
| Accounts payable and accrued liabilities | 3,475 | 5,454 | 5,685 | 4,048 | 9,893 |
| Accrued Expenses | 6,531 | 9,841 | 8,755 | 7,246 | 4,847 |
| TOTAL | $27,684 | $29,817 | $26,907 | $21,569 | $21,976 |
| Non-Current Liabilities | |||||
| Long Term Debt | 433 | 4,457 | 7,107 | 9,721 | 11,488 |
| Deferred Revenues | 6,500 | 7,154 | 7,571 | 7,824 | 6,379 |
| Other Non-Current Liabilities | 41,168 | 38,698 | 36,594 | 30,433 | 14,430 |
| TOTAL | $151,369 | $153,989 | $154,639 | $153,063 | $141,668 |
| Total Liabilities | $179,053 | $183,806 | $181,546 | $174,632 | $163,644 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,581 | 59,171 | 58,974 | 58,882 | 58,850 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -550,362 | -519,098 | -487,416 | -456,667 | -425,679 |
| Other shareholders' equity | -1,275 | -2,462 | -3,604 | -3,434 | -2,642 |
| TOTAL | $277,175 | $302,738 | $330,205 | $357,952 | $386,664 |
| Total Liabilities And Equity | $456,228 | $486,544 | $511,751 | $532,584 | $550,308 |